G

Gelteq Ltd
NASDAQ:GELS

Watchlist Manager
Gelteq Ltd
NASDAQ:GELS
Watchlist
Price: 0.8 USD -4.53%
Market Cap: 8.6m USD

Gelteq Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Gelteq Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
G
Gelteq Ltd
NASDAQ:GELS
Revenue
AU$165.7k
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Revenue
AU$413m
CAGR 3-Years
38%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Revenue
AU$228.7m
CAGR 3-Years
1 370%
CAGR 5-Years
295%
CAGR 10-Years
52%
Botanix Pharmaceuticals Ltd
ASX:BOT
Revenue
AU$5.8m
CAGR 3-Years
436%
CAGR 5-Years
102%
CAGR 10-Years
63%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Revenue
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nyrada Inc
ASX:NYR
Revenue
AU$2.6m
CAGR 3-Years
32%
CAGR 5-Years
19%
CAGR 10-Years
N/A
No Stocks Found

Gelteq Ltd
Glance View

Market Cap
8.6m USD
Industry
Pharmaceuticals

Gelteq Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2024-10-29. Gelteq Limited is an Australia-based clinical and science-based company. The firm is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The firm offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The firm also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

GELS Intrinsic Value
0.05 USD
Overvaluation 94%
Intrinsic Value
Price
G

See Also

What is Gelteq Ltd's Revenue?
Revenue
165.7k AUD

Based on the financial report for Jun 30, 2025, Gelteq Ltd's Revenue amounts to 165.7k AUD.

What is Gelteq Ltd's Revenue growth rate?
Revenue CAGR 3Y
4%

The average annual Revenue growth rates for Gelteq Ltd have been 4% over the past three years .

Back to Top